Explore
Validate
LearnHPA006288
antibody from Atlas Antibodies
Targeting: TP63
EEC3, KET, NBP, OFC8, p51, p53CP, p63, p73H, p73L, SHFM4, TP53CP, TP53L, TP73L
Western blot
ImmunohistochemistryAntibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- HPA006288 - Provider product page
- Provider
- Atlas Antibodies
- Proper citation
- Atlas Antibodies Cat#HPA006288, RRID:AB_1080334
- Product name
- Anti-TP63
- Antibody type
- Polyclonal
- Description
- Polyclonal Antibody against Human TP63, Gene description: tumor protein p63, Alternative Gene Names: EEC3, KET, NBP, OFC8, p51, p53CP, p63, p73H, p73L, SHFM4, TP53CP, TP53L, TP73L, Validated applications: WB, IHC, Uniprot ID: Q9H3D4, Storage: Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Reactivity
- Human, Rat
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 100 µl
- Concentration
- 0.3 mg/ml
- Storage
- Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Handling
- The antibody solution should be gently mixed before use.
Submitted references Bronchial epithelium epithelial-mesenchymal plasticity forms aberrant basaloid-like cells in vitro.
Expression of p53, p63, podoplanin and Ki-67 in recurring versus non-recurring oral leukoplakia.
SDCBP Modulates Stemness and Chemoresistance in Head and Neck Squamous Cell Carcinoma through Src Activation.
Uthaya Kumar DB, Motakis E, Yurieva M, Kohar V, Martinek J, Wu TC, Khoury J, Grassmann J, Lu M, Palucka K, Kaminski N, Koff JL, Williams A
American journal of physiology. Lung cellular and molecular physiology 2022 Jun 1;322(6):L822-L841
American journal of physiology. Lung cellular and molecular physiology 2022 Jun 1;322(6):L822-L841
Expression of p53, p63, podoplanin and Ki-67 in recurring versus non-recurring oral leukoplakia.
Sundberg J, Pandey S, Giglio D, Holmberg E, Kjeller G, Kovács A, Sand LP, Tokozlu B, Öhman J, Sapkota D, Hasséus B
Scientific reports 2021 Oct 21;11(1):20781
Scientific reports 2021 Oct 21;11(1):20781
SDCBP Modulates Stemness and Chemoresistance in Head and Neck Squamous Cell Carcinoma through Src Activation.
Mir C, Garcia-Mayea Y, Garcia L, Herrero P, Canela N, Tabernero R, Lorente J, Castellvi J, Allonca E, García-Pedrero J, Rodrigo JP, Carracedo Á, LLeonart ME
Cancers 2021 Oct 1;13(19)
Cancers 2021 Oct 1;13(19)
No comments: Submit comment
Supportive validation
- Submitted by
- Atlas Antibodies (provider)
- Enhanced method
- Orthogonal validation
- Main image
- Experimental details
- Immunohistochemistry analysis in human skin and kidney tissues using HPA006288 antibody. Corresponding TP63 RNA-seq data are presented for the same tissues.
- Sample type
- Human
- Protocol
- Protocol
